The total return over the past 12 months is -71.43% vs. +16.94% for the S&P 500. So far it's up -53.06% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (71.43%) | (42.92%) | (57.96%) | (72.19%) | N/A | N/A |
| Total Return CAGR | (71.43%) | (42.92%) | (57.96%) | (72.19%) | N/A | N/A |
| Revenue CAGR | (50.00%) | (65.58%) | (50.85%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Creative Medical Technology Holdings, Inc. (CELZ)
| Year | Start price | End price | CELZ Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.96 | $0.92 | (53.06%) | +14.51% | (67.57%) |
| 2025 | $2.31 | $1.96 | (15.15%) | +17.72% | (32.87%) |
| 2024 | $4.61 | $2.31 | (49.89%) | +24.89% | (74.78%) |
| 2023 | $3.81 | $4.61 | +21.00% | +26.19% | (5.19%) |
| 2022 | $22.10 | $3.81 | (82.76%) | (18.17%) | (64.59%) |
| 2021 | $139.00 | $22.10 | (84.10%) | +28.74% | (112.84%) |
| 2020 | $225.00 | $139.00 | (38.22%) | +18.37% | (56.59%) |
| 2019 | $7,410.00 | $225.00 | (96.96%) | +31.22% | (128.18%) |
| 2018 | $8,625.00 | $7,410.00 | (14.09%) | (4.56%) | (9.53%) |
| 2017 | $382,500.00 | $8,625.00 | (97.75%) | +21.70% | (119.45%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
